Beyond Air® Schedules Second Fiscal Quarter 2022 Financial Results Conference Call and Webcast
October 25, 2021
Beyond Air® Reports Positive Interim Results for LungFit® GO Pilot Study Using High Concentration Inhaled Nitric Oxide Self-Administered, At-Home for Nontuberculous Mycobacterial Lung Disease
October 20, 2021
Beyond Air® Provides Global Regulatory Update for LungFit® PH
September 21, 2021
Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 14, 2021
Beyond Air® Announces CFO Transition
August 20, 2021
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2022
August 10, 2021
Beyond Air® Schedules First Fiscal Quarter 2022 Financial Results Conference Call and Webcast
July 20, 2021
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in July 2021
July 8, 2021
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2021
June 10, 2021
Beyond Air® Reaches Settlement Agreement with Circassia for LungFit® PH
May 26, 2021

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications. Unsubscribe